Hyku Biosciences, a Covalent Precision Medicine Company, Announces CEO Transition for its Next Phase of Growth
March 11, 2024 08:00 ET
|
Hyku Biosciences
Kleem Chaudhary, Ph.D. appointed as President and Chief Executive Officer Dr. Chaudhary brings more than 20 years of leadership experience across multiple pharmaceutical and biotechnology companies ...